Cargando…
COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
Autores principales: | Paez Vargas, Juan José, Vidal González, Anxela, Pérez-Calvo, César, Flandes, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339404/ https://www.ncbi.nlm.nih.gov/pubmed/34366058 http://dx.doi.org/10.1016/j.chest.2021.03.028 |
Ejemplares similares
-
ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021) -
Was a Quarter of a Grain Too Large a Dose?
Publicado: (1877) -
Too risky, too large, too late, or too mild—Reasons for not treating ischemic stroke patients and the related outcomes
por: Behrndtz, Anne Brink, et al.
Publicado: (2022) -
Beyond Me, Too
por: Vaish, Richa, et al.
Publicado: (2016) -
Metoprolol in Critically Ill Patients With COVID-19
por: Clemente-Moragón, Agustín, et al.
Publicado: (2021)